FAKTOR-OPTIONSSCHEIN - ROCHE GS Share Price

Certificat

DE000MG1SED3

Market Closed - Börse Stuttgart 12:57:16 18/05/2024 am IST
8.07 EUR -2.77% Intraday chart for FAKTOR-OPTIONSSCHEIN - ROCHE GS
Current month-23.87%
1 month-27.10%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/24/17 8.07 -2.77%
16/24/16 8.3 -13.18%
15/24/15 9.56 -2.65%
14/24/14 9.82 -5.76%
13/24/13 10.42 +4.41%

Delayed Quote Börse Stuttgart

Last update May 18, 2024 at 12:57 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Morgan Stanley
WKN MG1SED
ISINDE000MG1SED3
Date issued 05/04/2024
Strike 313 CHF
Maturity Unlimited
Parity 9.3 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.6
Lowest since issue 8.07
Spread 0.03
Spread %0.37%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW